IntelGenx scaling-up cannabis-infused oral film production


IntelGenx (TSXV:IGX; OTCQX:IGXT) reported on progress in its cannabis-infused VersaFilm product co-development program with partner, Tilray (NASDAQ:TLRY).

“We are currently conducting scale-up activities for an anticipated commercial launch,” Dr. Horst Zerbe, CEO of IntelGenx, said in a statement.

“With the recent Cannabis Act amendments authorizing the sale of new classes of cannabis products, including oral films, we are well-positioned participate in the expanded cannabis market just as new product formats come online,” he added.

The company plans to unveil product details closer to commercial launch.


Sign up to our weekly BioTuesdays newsletter.